293 related articles for article (PubMed ID: 10494775)
1. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease.
Gardemann A; Lohre J; Katz N; Tillmanns H; Hehrlein FW; Haberbosch W
Thromb Haemost; 1999 Sep; 82(3):1121-6. PubMed ID: 10494775
[TBL] [Abstract][Full Text] [Related]
2. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
Ye S; Green FR; Scarabin PY; Nicaud V; Bara L; Dawson SJ; Humphries SE; Evans A; Luc G; Cambou JP
Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
[TBL] [Abstract][Full Text] [Related]
5. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease].
Zhang AY; Ji XW; Guan LX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):233-5. PubMed ID: 18393255
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.
Corsetti JP; Ryan D; Moss AJ; Rainwater DL; Zareba W; Sparks CE
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):548-54. PubMed ID: 18096824
[TBL] [Abstract][Full Text] [Related]
7. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
[TBL] [Abstract][Full Text] [Related]
9. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
[TBL] [Abstract][Full Text] [Related]
10. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
Doggen CJ; Bertina RM; Cats VM; Reitsma PH; Rosendaal FR
Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464
[TBL] [Abstract][Full Text] [Related]
11. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes.
Mansfield MW; Stickland MH; Grant PJ
Thromb Haemost; 1995 Oct; 74(4):1032-4. PubMed ID: 8560407
[TBL] [Abstract][Full Text] [Related]
13. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
[TBL] [Abstract][Full Text] [Related]
14. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease.
Onalan O; Balta G; Oto A; Kabakci G; Tokgozoglu L; Aytemir K; Altay C; Gurgey A; Nazli N
J Thromb Thrombolysis; 2008 Dec; 26(3):211-7. PubMed ID: 17721742
[TBL] [Abstract][Full Text] [Related]
16. Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
Haberbosch W; Gardemann A
Scand J Clin Lab Invest; 2005; 65(6):513-22. PubMed ID: 16179285
[TBL] [Abstract][Full Text] [Related]
17. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
[TBL] [Abstract][Full Text] [Related]
18. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.
Yamada N; Arinami T; Yamakawa-Kobayashi K; Watanabe H; Sohda S; Hamada H; Kubo T; Hamaguchi H
J Hum Genet; 2000; 45(3):138-41. PubMed ID: 10807538
[TBL] [Abstract][Full Text] [Related]
19. 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.
Koch W; Schrempf M; Erl A; Mueller JC; Hoppmann P; Schömig A; Kastrati A
Thromb Haemost; 2010 Jun; 103(6):1170-80. PubMed ID: 20352162
[TBL] [Abstract][Full Text] [Related]
20. Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.
Kitamura Y; Okumura K; Imamura A; Mizuno T; Tsuzuki M; Numaguchi Y; Matsui H; Murohara T
Clin Chim Acta; 2004 Sep; 347(1-2):209-16. PubMed ID: 15313160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
